Age: 69.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: She did a home test for COVID-19 and around 02FEB2023 and it was positive. She went to a clinic and they tested her and it came back positive/had mild COVID Disease /she had Runny nose and Hoarseness, and Course Voice; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (She did a home test for COVID-19 and around 02FEB2023 and it was positive. She went to a clinic and they tested her and it came back positive/had mild COVID Disease /she had Runny nose and Hoarseness, and Course Voice) in a 69-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 059F22A) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine (First Primary monovalent dose) on 23-Mar-2021, Moderna COVID-19 Vaccine (2nd Primary monovalent dose) on 20-Apr-2021, Moderna COVID-19 Vaccine (First Monovalent Booster dose) on 04-Nov-2021 and Moderna COVID-19 Vaccine (2nd Monovalent Booster dose) on 04-May-2022; for Product used for unknown indication: Influenza Vaccine in October 2022. Past adverse reactions to the above products included No adverse event with Influenza Vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine, Moderna COVID-19 Vaccine and Moderna COVID-19 Vaccine. Concomitant products included NIRMATRELVIR, LORATADINE and NIRMATRELVIR, RITONAVIR (PAXLOVID) for an unknown indication.    On 27-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (She did a home test for COVID-19 and around 02FEB2023 and it was positive. She went to a clinic and they tested her and it came back positive/had mild COVID Disease /she had Runny nose and Hoarseness, and Course Voice). At the time of the report, COVID-19 (She did a home test for COVID-19 and around 02FEB2023 and it was positive. She went to a clinic and they tested her and it came back positive/had mild COVID Disease /she had Runny nose and Hoarseness, and Course Voice) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 02-Feb-2023, SARS-CoV-2 test: Positive. On an unknown date, SARS-CoV-2 test: Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter did not provide any causality assessments.   No concomitant medicine were reported. It was reported that the patient had Runny nose, Hoarseness and Course Voice 1 week ago. The patient stated that she had mild COVID disease and did not have to be hospitalized. After the medication, the patient does not have runny nose or horsiness and her nose was not congested. The patient also reported that there is a new COVID in our area called, Cracid and patient is afraid of catching it.  The patient  would like to stay protected and asking Is there another COVID-19 shot, that she should receive?   Reporter did not allow further contact